Reena Khanna, MD, MSc, FRCP(C)

Associate Professor
University of Western Ontario

Saturday, April 2, 2022

10:35 am - 10:55 am
 

Are combination Biologics the next frontier in IBD?

In this presentation the principles and data regarding combination biologics will be explored.  The basis, potential adverse effects, and potential benefits of the off-label approach will be assessed.  Data from GI and other indications will be assessed.  The data underpinning various combinations will be explored.

Dr. Reena Khanna is an Associate Professor of Medicine at the University of Western Ontario, and a Clinician Researcher in the Program for Experimental Medicine. She completed her MD and Internal Medicine residency at the University of Western Ontario, Gastroenterology fellowship at McMaster University. Dr. Khanna completed an advanced fellowship in inflammatory bowel disease (IBD) at the Cleveland Clinic, followed by a research fellowship in international IBD clinical trials at the University of Western Ontario. She completed an MSc in clinical epidemiology at McMaster University. Her clinical and research interest are clinical trial design, new therapeutics, outcome measures. She has designed, conducted and published several studies, including the first cluster study in IBD. Dr. Khanna holds international grants and was awarded the Crohn’s Colitis Canada’s rising star award for her research contributions.